Abstract
A 15 year old girl with a family history of type 1 multiple endocrine adenomatosis presented with reversible neurological disturbances, hypoglycaemia and hyperinsulinaemia. Initial radiology was normal, but portal venous sampling suggested an insulinoma in the tail of the pancreas which was removed with conservation of the spleen. Hypoglycaemia persisted despite high doses of diazoxide and intravenous dextrose. A second laparotomy revealed a pancreatic endocrine tumour and sub-total pancreatectomy was performed. Histology revealed islet cell microadenomatosis. Hypoglycaemia persisted despite treatment with somatostatin analogues and 40% intravenous dextrose was required to maintain normoglycaemia. A possible lesion near the splenic hilum on computed tomographic scan was reported as a splenunculus although further peripheral, hepatic and portal venous sampling suggested hepatic or systemic lesions. A positron emission scan and selective visceral angiography suggested a lesion in the left upper quadrant. Acute lactic acidosis, rhabdomyolysis and renal failure supervened. Post mortem revealed the putative 'splenunculus' to be a residual insulinoma, whilst the splenic vein was thrombosed, accounting in part for discrepant venous sampling data. Hyperinsulinaemia in type 1 multiple endocrine adenomatosis may require more aggressive surgical and hormonal intervention than when dealing with solitary insulinomas. Insulinomas may mimic developmental abnormalities on computed tomographic scanning.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonfils S. New somatostatin molecule for management of endocrine tumours. Gut. 1985 May;26(5):433–437. doi: 10.1136/gut.26.5.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doppman J. L. Multiple endocrine syndromes--a nightmare for the endocrinologic radiologist. Semin Roentgenol. 1985 Jan;20(1):7–16. doi: 10.1016/0037-198x(85)90019-7. [DOI] [PubMed] [Google Scholar]
- Kvols L. K., Buck M., Moertel C. G., Schutt A. J., Rubin J., O'Connell M. J., Hahn R. G. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). Ann Intern Med. 1987 Aug;107(2):162–168. doi: 10.7326/0003-4819-107-2-162. [DOI] [PubMed] [Google Scholar]
- Lips C. J., Vasen H. F., Lamers C. B. Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol. 1984;2(2):117–184. doi: 10.1016/s1040-8428(84)80017-7. [DOI] [PubMed] [Google Scholar]
- Long R. G., Barnes A. J., Adrian T. E., Mallinson C. N., Brown M. R., Vale W., Rivier J. E., Christofides N. D., Bloom S. R. Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet. 1979 Oct 13;2(8146):764–767. doi: 10.1016/s0140-6736(79)92115-9. [DOI] [PubMed] [Google Scholar]
- Sobey W. J., Beer S. F., Carrington C. A., Clark P. M., Frank B. H., Gray I. P., Luzio S. D., Owens D. R., Schneider A. E., Siddle K. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J. 1989 Jun 1;260(2):535–541. doi: 10.1042/bj2600535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stefanini P., Carboni M., Patrassi N., Basoli A. Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery. 1974 Apr;75(4):597–609. [PubMed] [Google Scholar]
- Vance J. E., Stoll R. W., Kitabchi A. E., Williams R. H., Wood F. C., Jr Nesidioblastosis in familial endocrine adenomatosis. JAMA. 1969 Mar 3;207(9):1679–1682. [PubMed] [Google Scholar]